Niagen Bioscience, Inc. — Director's Dealing 2014

Jun 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2014-06-18

Reporting Person: Varvaro Thomas C (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-18	Employee Stock Options (right to buy)	$1.25	A	125000	Acquired	2024-06-18	Common Stock (125000)	Direct

Footnotes

F1: Options vest 25% on June 18, 2015 with the remainder vesting 1/36th per month over three years thereafter.

F2: The total includes 1,904,499 options under different terms.